论文部分内容阅读
天士力自1994年成立以来,坚持打造现代中药第一品牌,不断推进大健康产业的发展。在做专做精现代中药的基础上,向生物药、化学药、特色专科医疗行业扩展,形成以医药为主要领域的生命安全产业板块;并逐步进入保健品、健康食品、化妆品、安全饮用水、生物普洱茶等生命健康产业领域。天士力集团以全面国际化为目标,全力推进“一个核心带两翼”大健康产业高端化,已经形成了以生物医药产业为核心、以健康产品产业和健康管理与服务产业为两翼的大健康产业全新格局。天士力以现代中药奠基立业,从现代中药的研发和生产开始,带动形成了一条集药物研发、药材种植、有效中药组分分离、制剂生产和市场营销各环节的现代中药产业链,建设了国内领先的现代中药数字化制造平台、数字化提取中心,以及中国最大的中药冻干粉针剂生产基
Tasly since its establishment in 1994, insist on building the first brand of modern Chinese medicine, and constantly promote the development of large health industry. On the basis of specializing in modern Chinese medicine, it will expand its bio-medicine, chemical medicine and specialties medical industry to form a life safety industry sector that takes medicine as its main area. It will also gradually enter into the fields of health products, health foods, cosmetics, safe drinking water , Biological Pu’er tea and other areas of life and health industry. Tasly Group to fully internationalization as the goal, to promote “a core with two wings” high-end large health industry, has formed a biomedical industry as the core, health products industry and health management and service industries for the two wings of the health A new industry pattern. Tasly established itself as the foundation of modern Chinese medicine. From the research and development and production of modern Chinese medicine, Tasly has led to the formation of a modern Chinese medicine industrial chain that integrates drug research and development, cultivation of medicinal herbs, separation of effective Chinese medicine components, production of preparations and marketing and construction of a leading Chinese medicine industry chain Modern digital medicine manufacturing platform, digital extraction center, as well as China’s largest Chinese medicine freeze-dried powder production base